000 | 01983 a2200577 4500 | ||
---|---|---|---|
005 | 20250517215324.0 | ||
264 | 0 | _c20191029 | |
008 | 201910s 0 0 eng d | ||
022 | _a1365-2060 | ||
024 | 7 |
_a10.1080/07853890.2018.1474002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShapiro, Nathan I | |
245 | 0 | 0 |
_aA prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever. _h[electronic resource] |
260 |
_bAnnals of medicine _c08 2018 |
||
300 |
_a420-429 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAmbulatory Care Facilities |
650 | 0 | 4 |
_aBacterial Infections _xblood |
650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aDiagnosis, Differential |
650 | 0 | 4 | _aEmergency Service, Hospital |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFever _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyxovirus Resistance Proteins _xblood |
650 | 0 | 4 | _aPoint-of-Care Testing |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRespiratory Tract Infections _xblood |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aVirus Diseases _xblood |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aSelf, Wesley H | |
700 | 1 | _aRosen, Jeffrey | |
700 | 1 | _aSharp, Stephan C | |
700 | 1 | _aFilbin, Michael R | |
700 | 1 | _aHou, Peter C | |
700 | 1 | _aParekh, Amisha D | |
700 | 1 | _aKurz, Michael C | |
700 | 1 | _aSambursky, Robert | |
773 | 0 |
_tAnnals of medicine _gvol. 50 _gno. 5 _gp. 420-429 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/07853890.2018.1474002 _zAvailable from publisher's website |
999 |
_c28404756 _d28404756 |